BAPHOMET is a version of PAZUZU.
Baphomet has two words tattooed on his arms - one of the words is COAGULA which means ‘sticky’, or ‘jellied’ or ‘clotted’.
Crab blood is being used in the development of Covid vaccines and testing kits - and it’s active ingredient is a ‘COAGULA’ agent.
Just a coincidence?
Crab blood is being used to create microscopic clots in samples of blood taken from patients and may even end up as a vaccine ingredient if experimental trials go ahead. The BBC say this blue crab blood is an important ‘key’ to the Covid vaccine.
Inside the horseshoe crab's blood cell (called the amebocyte) are the proteins of its blood clotting system. To take advantage of this biological idiosyncrasy, pharmaceutical companies burst the cells that contain the chemical, called coagulogen.
Then, they can use the coagulogen to detect contamination in any solution that might come into contact with blood. If there are dangerous bacterial endotoxins in the liquid—even at a concentration of one part per trillion—the horseshoe crab blood extract will go to work, turning the solution into what scientist Fred Bang, who co-discovered the substance, called a "gel."
According to NatGeo; Blue crab blood provides the only known natural source of limulus amebocyte lysate, a substance that detects a contaminant called endotoxin. If even tiny amounts of endotoxin — a type of bacterial toxin — make their way into vaccines, injectable drugs, or other sterile pharmaceuticals such as artificial knees and hips, the results can be deadly.
“All pharmaceutical companies around the world rely on these crabs. When you think about it, your mind is boggled by the reliance that we have on this primitive creature,” says Barbara Brummer, state director for The Nature Conservancy in New Jersey.
The U.S. Food and Drug Administration (FDA) requires that intravenous drugs and any medical equipment coming in contact with the body must first pass through the crab's blood, from needles to surgical implants including pacemakers. As a result, thousands more of us survive such procedures.
The method is established but undergoes constant improvement, according to John Dubczak, General Manager at Charles River Laboratories, which manufactures and globally distributes LAL products. "Detection is down to one part per trillion," he said. "But we can take it down to a tenth of a trillion, and further orders of magnitude more sensitive." Charles River has adapted the system into a more resource-efficient, handheld kit requiring as little as 5% of the blood solution.